High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

This publication has 10 references indexed in Scilit:

• A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy
  Bone Marrow Transplantation, 2006
• Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone
  Transplantation and Cellular Therapy, 2006
• High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol
  European Journal Of Cancer, 2005
• High-Dose Chemotherapy for Breast Cancer: The French PEGASE Experience
  Cancer Control, 2003
• High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry
  Journal of Clinical Oncology, 2002
• An On-Site Audit of the South African Trial of High-Dose Chemotherapy for Metastatic Breast Cancer and Associated Publications
  Journal of Clinical Oncology, 2001
• A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study
  European Journal Of Cancer, 2001
• Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
  New England Journal of Medicine, 2000
• High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.
  Journal of Clinical Oncology, 1992
• High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
  Journal of Clinical Oncology, 1988